Dawaa Reference

Clinical reference

Benign Eye Tumor

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources2 sources

ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class FD25.00 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care

Verified against3 documents
  • No dose - referral pathway, no medicine given in primary care
  • Benign and Malignant Iris Tumors - disease-level clinical article (benign-eye-tumor-clinical.txt)
  • Benign and Malignant Iris Tumors - disease-level clinical article (benign-eye-tumor-full.txt)

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (2)

  • Patients often notice a discolored spot or patch on the iris themselves
  • Blurred vision and pain can occur but are not typical [blurred vision · eye pain]

Signs — what you find (7)

  • A pigment-epithelium iris cyst is one-sided, darker in color, and lets light pass through it [cyst]
  • A stromal iris cyst tends to appear in the first decade of life with a smooth, see-through front surface [cyst]
  • An iris nevus is usually smaller than a melanoma, under 3 mm across and 1 mm thick
  • Iris pigment epithelium adenoma shows up as a dark grey lesion near the outer edge of the iris, sometimes with several nodules
  • Iris leiomyoma is typically a single, slow-growing, well-defined nodule that is lightly or not pigmented
  • Yellow nodules on the iris with bleeding into the eye and skin lesions point to juvenile xanthogranuloma [bleeding · skin lesions]
  • Vascular growths on the iris often show up with sudden bleeding into the eye and resulting blurry vision [bleeding]

Tests (6)

  • Checking eye pressure and the drainage angle is recommended given the risk of glaucoma with these growths
  • Ultrasound biomicroscopy helps size the lesion and tell a solid mass apart from a fluid-filled one
  • Fine-needle sampling can settle the diagnosis when imaging alone is not conclusive
  • Immunohistochemistry and electron microscopy are needed to confirm a leiomyoma, since it often mimics other growths
  • Chest imaging is advised when sarcoidosis is suspected as the cause of iris nodules
  • Fluorescein angiography is key to working up a vascular growth on the iris

If not this — what else fits (9)

  • Inflammatory granuloma
  • Epithelial ingrowth
  • Congenital iris heterochromia
  • Fuchs heterochromic iridocyclitis
  • Iris nevus syndrome
  • Pigment dispersion syndrome
  • Hemosiderosis
  • Pigmentary glaucoma
  • Ocular siderosis

SourceStatPearls "Benign and Malignant Iris Tumors" - disease-level clinical article

Presentation findings are traced to the source above.

1

NO DRUG THERAPY IN PRIMARY CARE (RECOGNITION & REFERRAL)

1st line
Adult dose and duration

A non-cancerous growth of the eye or its surrounding structures; a GP refers to ophthalmology for assessment and possible removal rather than treating it. - Refer

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

A non-cancerous growth of the eye or its surrounding structures; a GP refers to ophthalmology for assessment and possible removal rather than treating it.

Cautions
  • RED FLAG - Visual field defects, proptosis, or increased intraocular pressure: assess urgently and refer.
  • Rare in Egyptian primary care.
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - Patients should seek immediate medical attention for changes in vision, acute eye pain, or visible changes in the tumor due to secondary glaucoma risk.
  • RED FLAG - Irregularly contoured lesions thicker than 0.5-1.0 mm, increased vasculature, spontaneous hyphema, or pupillary peeking indicate potential malignancy.
  • RED FLAG - A change in the size or colour of the lesion, or bleeding from it: re-evaluate for malignant transformation.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.